FANS FOR THE CURE

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2003

Legal Domicile

Principal Officer

EDWIN RANDALL

Phone

8883014414

Tax Period

2023-01-01 to 2023-12-31

FANS FOR THE CURE, founded in 2003, is a small nonprofit in the Philanthropy & Grantmaking sector that reported $195K in total revenue in fiscal year 2023. Revenue grew 14% year-over-year, indicating healthy expansion. Expenses of $296K exceeded revenue, resulting in a 52% operating deficit.

Mission

TO PROVIDE PROGRAMS, SERVICES, AND ADVOCACY TO MEN AND FAMILIES AFFECTED BY PROSTATE CANCER.

Program Service Accomplishments

Program 1

Expenses: $58,000

Fans for the Cure offered online women's and men's support groups. There were fifty-three (53) meetings in 2023, a significant number of which were attended by doctors, researchers, and other...

Fans for the Cure offered online women's and men's support groups. There were fifty-three (53) meetings in 2023, a significant number of which were attended by doctors, researchers, and other healthcare professionals who made presentations and answered participants' questions. Over 450 men and women had officially registered for the support group by year-end 2023.

Program 2

Expenses: $103,819

September 21, 2023 -- Partnering with Montefiore Einstein and the New York Yankees, Fans for the Cure participated in a prostate cancer screening event at Yankee Stadium prior to and during the...

September 21, 2023 -- Partnering with Montefiore Einstein and the New York Yankees, Fans for the Cure participated in a prostate cancer screening event at Yankee Stadium prior to and during the evening game. 166 men, including employees and NYPD, took advantage of the opportunity to take a free blood test that tested for elevated PSA, a marker for prostate cancer. September 28, 2023 -- In collaboration with the New York Presbyterian Healthcare System and the New York Mets, Fans for the Cure participated in a prostate cancer screening at Citi Field in Queens, New York. 276 men, including employees and NYPD, were tested on site. March - November 2023 -- Fans for the Cure participated in over thirty community health events which took place in medically-underserved communities on Long Island (NY) as part of a grant and consulting agreement with Molloy University.

Program 3

Expenses: $53,286

Fans for the Cure continued to produce the Stay in the Game podcast throughout 2023. Guests included doctors, researchers, public health officials, and cancer survivors. Discussions focused on...

Fans for the Cure continued to produce the Stay in the Game podcast throughout 2023. Guests included doctors, researchers, public health officials, and cancer survivors. Discussions focused on people's experiences with prostate cancer. There were fifteen podcasts released in 2023.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $143,656

Program Service Revenue $0

Investment Income $15

Other Revenue $50,851

TOTAL REVENUE $194,522

Expense Breakdown

Grants Paid $0

Salaries & Benefits $35,621

Fundraising Expenses $39,153

Program Expenses $215,105

Other Expenses $260,424

TOTAL EXPENSES $296,045

Year-over-Year Comparison

	2023	2022	Change
Revenue	$194,522	$170,109	+0.1%
Expenses	$296,045	$368,384	-0.2%
Net Income	$-101,523	$-198,275	-0.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$33,068

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
EDWIN WAYNE RANDALL	FOUNDER & CAO	40.0	Officer	$30,000	$3,068	$33,068
STEVE GARVEY	CHAIRMAN	1.0	Director	$0	$0	$0
ANDREW WINCEL	DIRECTOR	1.0	Director	$0	$0	$0
JOHN WHITE	DIRECTOR	1.0	Director	$0	$0	$0
MICHAEL COREY	DIRECTOR	1.0	Director	$0	$0	$0
DAVID BAGATELLE	DIRECTOR	1.0	Director	$0	$0	$0
AVIS RICHARDS	DIRECTOR	1.0	Director	$0	$0	$0
EDWARD THOMPSON	DIRECTOR	1.0	Director	$0	$0	$0
WILLIAM DOWLING	DIRECTOR	1.0	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$194,522	$296,045	$33,446	$-101,523
2022	$170,109	$368,384	$39,536	$-198,275
2021	$174,687	$308,732	$225,191	$-134,045
2020	$111,876	$343,127	$229,759	$-231,251
2019	$582,737	$369,302	$435,128	$213,435
2018	$163,062	$230,360	$227,813	$-67,298
2017	$360,999	$212,471	$269,184	$148,528
2017	$360,999	$212,471	$269,184	$148,528